Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021

SELL
$8.38 - $10.18 $164,256 - $199,538
-19,601 Closed
0 $0
Q2 2021

Aug 23, 2021

SELL
$9.9 - $11.56 $1.55 Million - $1.8 Million
-156,140 Reduced 88.85%
19,601 $194,000
Q1 2021

May 04, 2021

BUY
$10.34 - $12.81 $1.06 Million - $1.31 Million
102,205 Added 138.99%
175,741 $2.03 Million
Q4 2020

Feb 08, 2021

SELL
$8.61 - $11.04 $242,888 - $311,438
-28,210 Reduced 27.73%
73,536 $710,000
Q3 2020

Oct 28, 2020

SELL
$8.57 - $12.69 $194,778 - $288,418
-22,728 Reduced 18.26%
101,746 $917,000
Q2 2020

Aug 04, 2020

SELL
$8.12 - $13.12 $13,479 - $21,779
-1,660 Reduced 1.32%
124,474 $1.54 Million
Q1 2020

Apr 29, 2020

SELL
$6.69 - $13.45 $2,676 - $5,380
-400 Reduced 0.32%
126,134 $1.13 Million
Q4 2019

Jan 31, 2020

SELL
$6.53 - $10.72 $28,496 - $46,782
-4,364 Reduced 3.33%
126,534 $1.24 Million
Q3 2019

Oct 30, 2019

SELL
$6.16 - $9.6 $69,546 - $108,384
-11,290 Reduced 7.94%
130,898 $901,000
Q2 2019

Aug 05, 2019

BUY
$8.12 - $15.72 $143,951 - $278,684
17,728 Added 14.24%
142,188 $1.31 Million
Q1 2019

May 07, 2019

SELL
$15.58 - $20.01 $85,300 - $109,554
-5,475 Reduced 4.21%
124,460 $1.95 Million
Q4 2018

Feb 01, 2019

SELL
$14.59 - $23.84 $1.72 Million - $2.81 Million
-118,025 Reduced 47.6%
129,935 $2 Million
Q3 2018

Oct 31, 2018

BUY
$21.06 - $25.65 $33,169 - $40,398
1,575 Added 0.64%
247,960 $5.34 Million
Q2 2018

Aug 03, 2018

SELL
$16.77 - $24.71 $110,614 - $162,987
-6,596 Reduced 2.61%
246,385 $5.99 Million
Q1 2018

May 04, 2018

SELL
$16.68 - $22.07 $160,027 - $211,739
-9,594 Reduced 3.65%
252,981 $4.32 Million
Q4 2017

Feb 01, 2018

SELL
$11.23 - $19.1 $693,553 - $1.18 Million
-61,759 Reduced 19.04%
262,575 $4.98 Million
Q3 2017

Nov 02, 2017

BUY
$15.41 - $32.17 $5 Million - $10.4 Million
324,334
324,334 $5.71 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Greatmark Investment Partners, Inc. Portfolio

Follow Greatmark Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greatmark Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greatmark Investment Partners, Inc. with notifications on news.